Filing Details
- Accession Number:
- 0001214659-20-010485
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-16 17:36:47
- Reporting Period:
- 2020-12-14
- Accepted Time:
- 2020-12-16 17:36:47
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1576263 | Mirati Therapeutics Inc. | MRTX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1240122 | G Michael Grey | C/O Mirati Therapeutics Inc. 9393 Town Centre Drive, Ste 200 San Diego CA 92121 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-12-14 | 10,900 | $16.84 | 15,156 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-12-14 | 379 | $241.22 | 14,777 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-12-14 | 857 | $242.29 | 13,920 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-12-14 | 1,815 | $243.35 | 12,105 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-12-14 | 1,653 | $244.45 | 10,452 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-12-14 | 1,284 | $245.11 | 9,168 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-12-14 | 1,807 | $246.73 | 7,361 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-12-14 | 1,997 | $247.62 | 5,364 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-12-14 | 1,019 | $248.55 | 4,345 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-12-14 | 89 | $249.42 | 4,256 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non Qualified Stock Option (right to buy) | Disposition | 2020-12-14 | 10,900 | $0.00 | 10,900 | $16.84 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2017-11-05 | 2024-11-04 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2020.
- This transaction was executed in multiple trades at prices ranging from $240.93 to $241.91. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $241.93 to $242.905. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $242.94 to $243.875. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $243.97 to $244.915. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $245.00 to $245.915. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $246.29 to $247.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $247.30 to $248.23. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $248.30 to $249.19. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
